Understanding the mechanisms contributing to the cellular release of NAMPT and its dual role as an enzyme in extracellular NAD metabolism versus ligand activation of TLR4 may lead to novel therapeutics for CKD. This evidence concerns the gene TLR4 and chronic kidney disease.